MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more
Market Cap & Net Worth: MedX Health Corp (MDXHF)
MedX Health Corp (PINK:MDXHF) has a market capitalization of $262.35K ($262.35K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #39774 globally and #12940 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MedX Health Corp's stock price $0.00 by its total outstanding shares 327932315 (327.93 Million).
MedX Health Corp Market Cap History: 2015 to 2025
MedX Health Corp's market capitalization history from 2015 to 2025. Data shows change from $15.94 Million to $262.35K (-35.30% CAGR).
MedX Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MedX Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.54x
MedX Health Corp's market cap is 0.54 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $15.94 Million | $1.17 Million | -$499.25K | 13.61x | N/A |
| 2016 | $46.99 Million | $817.05K | -$1.34 Million | 57.51x | N/A |
| 2017 | $31.15 Million | $1.09 Million | -$1.60 Million | 28.50x | N/A |
| 2018 | $33.81 Million | $1.09 Million | -$4.19 Million | 31.09x | N/A |
| 2019 | $22.96 Million | $860.25K | -$3.28 Million | 26.68x | N/A |
| 2020 | $29.51 Million | $530.07K | -$3.20 Million | 55.68x | N/A |
| 2021 | $19.68 Million | $563.10K | -$5.32 Million | 34.94x | N/A |
| 2022 | $6.56 Million | $510.61K | -$5.13 Million | 12.84x | N/A |
| 2023 | $13.12 Million | $456.09K | -$4.58 Million | 28.76x | N/A |
| 2024 | $262.35K | $489.70K | -$3.65 Million | 0.54x | N/A |
Competitor Companies of MDXHF by Market Capitalization
Companies near MedX Health Corp in the global market cap rankings as of March 19, 2026.
Key companies related to MedX Health Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
MedX Health Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, MedX Health Corp's market cap moved from $15.94 Million to $ 262.35K, with a yearly change of -35.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $262.35K | 0.00% |
| 2024 | $262.35K | -98.00% |
| 2023 | $13.12 Million | +100.00% |
| 2022 | $6.56 Million | -66.67% |
| 2021 | $19.68 Million | -33.33% |
| 2020 | $29.51 Million | +28.57% |
| 2019 | $22.96 Million | -32.10% |
| 2018 | $33.81 Million | +8.53% |
| 2017 | $31.15 Million | -33.71% |
| 2016 | $46.99 Million | +194.86% |
| 2015 | $15.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MedX Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $262.35K USD |
| MoneyControl | $262.35K USD |
| MarketWatch | $262.35K USD |
| marketcap.company | $262.35K USD |
| Reuters | $262.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.